Tamoxifen in Duchenne muscular dystrophy: A multicentre, randomised, double-blind, placebo-controlled, phase 3 safety and efficacy 48-week trialB. Henzi,S. Schmidt,S. Nagy, D. Rubino-Nacht, S. Schaedelin, N. Putananickal,P. Hafner,O. Dorchies,D. FischerNEUROMUSCULAR DISORDERS（2022）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
